ABI-008 Trial in Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ABI-008 (nab-docetaxel)
Sponsor: Celgene